市场调查报告书
商品编码
1492504
消费者基因组学市场:按产品/服务、技术、应用划分 - 2024 年至 2030 年全球预测Consumer Genomics Market by Product & Service (Consumables, Services, Systems & Software), Technology (Microarray, Nucleic Acid Extraction & Purification, Polymerase Chain Reaction (PCR)), Application - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年消费者基因组市场规模为25.6亿美元,预计2024年将达31亿美元,2030年将达到100.8亿美元,复合年增长率为21.62%。
消费者基因组学分析个人的基因组成,提供对遗传、某些健康状况的倾向、对药物的潜在反应以及其他个人特征的深入了解。此资讯通常透过直接面向消费者 (DTC) 的基因检测套组提供。然后在实验室中对 DNA 进行分析,并透过安全的线上平台提供结果。随着人们健康意识的增强,对从遗传讯息中获得的个人化健康见解的兴趣与日俱增,消费者对基因组相关产品的需求也在增加。人们对遗传疾病的认识和诊断不断提高,鼓励个人了解自己的遗传风险并积极管理自己的健康。然而,基因检测结果的准确性和可靠性各不相同,并受到基因资料解释技术和品质的影响。对基因资料隐私和基因检测的伦理影响的担忧可能会阻止个人使用这些服务。持续的研究和开发将开发出更先进、更准确和更具成本效益的基因组测试技术,扩大消费者基因组学的范围和吸引力。消费者基因组学有潜力为个人化医疗领域做出重大贡献,该领域支持根据个人基因图谱量身定制的治疗方法。
主要市场统计 | |
---|---|
基准年[2023] | 25.6亿美元 |
预测年份 [2024] | 31亿美元 |
预测年份 [2030] | 100.8亿美元 |
复合年增长率(%) | 21.62% |
区域洞察
在美洲,特别是在美国,消费者基因组学市场高度发达,并受到消费者对个人化健康见解的倾向的推动。由于广泛的教育倡议和广泛的营销,美洲地区的消费者对基因组学的认识非常高。现代技术的高度普及和生物技术的大量投资正在推动该地区的成长。在欧洲,英国、德国、法国等国家由于消费者意识高、健康意识强而处于领先地位。基因组学研究和开发得到政府资金的大力支持,特别是在这些国家。欧盟 (EU) 关于基因资料的严格隐私法规也确保消费者权利得到充分保护,从而显着影响注重隐私的产品的市场动态。亚太地区代表了消费者基因组学的发展,人们对健康和保健、遗传疾病的认识不断提高,政府大力支持,对生物技术研究进行了大量投资。开发负担得起的家庭基因检测套组的努力有可能推动消费者基因组市场的发展。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在消费者基因组学市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对消费者基因组学市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。透过彻底评估其目前在消费者基因组学市场中的地位,公司可以做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[189 Pages Report] The Consumer Genomics Market size was estimated at USD 2.56 billion in 2023 and expected to reach USD 3.10 billion in 2024, at a CAGR 21.62% to reach USD 10.08 billion by 2030.
Consumer genomics involves the analysis of an individual's genetic makeup to provide insights into heritage, predisposition to certain health conditions, potential response to medications, and other personal traits. This information is typically provided using direct-to-consumer (DTC) genetic testing kits, which consumers can use at home by providing a DNA sample through saliva or a cheek swab. The DNA is then analyzed in a lab, and results are delivered through secure online platforms. As people become more health-conscious, there is a growing interest in personalized health insights derived from genetic information, leading to an increased need for consumer genomic products. There is an increasing awareness and diagnosis of genetic disorders, encouraging individuals to understand their genetic risks and manage health proactively. However, there can be variability in the accuracy and reliability of genetic testing results, influenced by the quality of technology and interpretation of genetic data. Concerns about the privacy of genetic data and the ethical implications of genetic testing can deter individuals from using these services. Ongoing research and development are likely to result in more advanced, accurate, and cost-effective genomic testing technologies, broadening the scope and appeal of consumer genomics. Consumer genomics has the potential to contribute significantly to the field of personalized medicine, helping tailor medical treatments to individuals' genetic profiles.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.56 billion |
Estimated Year [2024] | USD 3.10 billion |
Forecast Year [2030] | USD 10.08 billion |
CAGR (%) | 21.62% |
Regional Insights
In the Americas, particularly in the United States, the consumer genomics market is highly developed and driven by a consumer's inclination toward personalized health insights. The Americas region boasts a significant level of consumer awareness about genomics, owing to extensive educational initiatives and widespread marketing. High penetration of modern technology and substantial investments in biotechnology fuel the growth in this region. Europe presents a diverse landscape in consumer genomics, with countries such as the UK, Germany, and France leading due to high consumer awareness and health-conscious populations. Research and development in genomics are strongly supported by government funding, particularly in these countries. The European Union's stringent privacy regulations on genetic data also ensure consumer rights are adequately protected, influencing the market dynamics heavily towards privacy-conscious offerings. APAC region represents an evolving landscape for consumer genomics, driven by rising awareness about health and wellness and genetic diseases, significant government backing, and substantial investments in biotechnology research. Efforts to develop affordable, home-based genetic testing kits have the potential to boost the consumer genomics market.
Market Insights
The market dynamics represent an ever-changing landscape of the Consumer Genomics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Consumer Genomics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Consumer Genomics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Launch of Nucleus Genomics' Comprehensive DNA Analysis Services
Nucleus Genomics has introduced a novel DNA analysis product designed to enhance personalized medicine accessibility. The company is also initiating pre-orders for its advanced whole-genome sequencing service, aiming for a detailed analysis of a customer's complete DNA set. [Published On: 2024-03-25]
Strategic Partnership Expansion Between DnaNudge and NantNudge to Enhance Global Access to Genomics and AI-Driven Diagnostics
DnaNudge entered into a significant multi-million-dollar partnership with NantNudge, a company focused on advancing genomics combined with artificial intelligence at the point of decision. This collaboration aims to extend lab-free, rapid diagnostic solutions globally, particularly in the Americas and Africa. NantNudge will be responsible for creating and supplying cutting-edge diagnostic tools tailored for non-invasive health monitoring, dietary, and skincare advisement, alongside real-time PCR diagnostics for infectious diseases and cancers. [Published On: 2023-11-06]
Quest Diagnostics Unveils 'Genetic Insights': A New Consumer-Centric Genetic Testing Service
Quest Diagnostics has introduced 'Genetic Insights,' a consumer-oriented genetic testing service aimed at assessing the risk for inheritable diseases. The test uses a saliva sample to analyze 36 genes to predict the risk for 24 genetic conditions, such as breast and colon cancers, cardiovascular and blood disorders, and carrier status for diseases such as cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. The service also offers personalized health reports and access to genetic counseling, enhancing individual understanding of their genetic health landscape. [Published On: 2023-07-11]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Consumer Genomics Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Consumer Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 23andMe, Inc., Agilent Technologies, Inc., Ambry Genetics Corporation by Konica Minolta, Inc., Ancestry, BGI Group, Bio-Rad Laboratories, Inc., Color Health, Inc., Dante Labs Inc., Decode Genetics by Amgen Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Full Genomes Corporation, Inc., Gene by Gene, Ltd., Helix OpCo, LLC, Illumina, Inc., Invitae Corporation, Living DNA Ltd, MyHeritage Ltd., Nebula Genomics, Inc. by ProPhase Labs, Inc., Oxford Nanopore Technologies PLC, QIAGEN GmbH, SeqLL Inc., Thermo Fisher Scientific, Inc., and Veritas Intercontinental SL by LetsGetChecked, Inc..
Market Segmentation & Coverage